{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:01:48Z","timestamp":1793152908778,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"HEFCE funding from Queen Mary University of London"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inhibitors of ATR, a central kinase controlling DNA replication origin firing and cellular checkpoints, are undergoing clinical trials, yet mechanisms underpinning sensitivity to ATR inhibitors (ATRi) and patient stratification biomarkers are lacking. Here, we perform in parallel, proteomics, transcriptomics and functional analyses and demonstrate that sensitive cancer cell lines have higher expression of DNA replication initiation factors, and exhibit higher origin firing, increased pan-nuclear \u03b3H2AX signals and cell death upon ATRi treatment. ATRi sensitivity is causally associated with origin firing rates, since we could modulate ATRi sensitivity by either up- or down-regulating origin firing capacity using CDC7 inhibition, CDK2 inhibition or CDC45 overexpression in both breast and colorectal cancer cells. High expression of replication initiation factors predicts ATRi sensitivity across cell lines from multiple cancer types and acute myeloid leukemia patient samples. This study reveals a contribution of lethal origin firing capacity to ATR sensitivity, providing key steps towards developing a multimodal clinically applicable biomarker.<\/jats:p>","DOI":"10.1038\/s41467-026-74588-7","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T21:56:23Z","timestamp":1781906183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Replication origin firing capacity indicates ATR inhibitor sensitivity"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0431-3736","authenticated-orcid":false,"given":"A.","family":"Lumeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2349-2920","authenticated-orcid":false,"given":"P. L.","family":"Pfuderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0076-6853","authenticated-orcid":false,"given":"J. A.","family":"Scarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6993-9890","authenticated-orcid":false,"given":"E.","family":"Maniati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1307-5450","authenticated-orcid":false,"given":"M. A.","family":"Guscott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1292-7965","authenticated-orcid":false,"given":"F. B.","family":"Copley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7804-4121","authenticated-orcid":false,"given":"E. L.","family":"Alard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2509-9599","authenticated-orcid":false,"given":"J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3426-2274","authenticated-orcid":false,"given":"P. R.","family":"Cutillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-0827","authenticated-orcid":false,"given":"F. K.","family":"Mardakheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0326-8200","authenticated-orcid":false,"given":"M. A.","family":"Boemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7797-2583","authenticated-orcid":false,"given":"J. V.","family":"Forment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9987-4511","authenticated-orcid":false,"given":"S. E.","family":"McClelland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"74588_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2897","volume":"16","author":"MK Zeman","year":"2014","unstructured":"Zeman, M. K. & Cimprich, K. A. Causes and consequences of replication stress. Nat. Cell Biol. 16, 2 (2014).","journal-title":"Nat. Cell Biol."},{"key":"74588_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1158\/2767-9764.CRC-22-0168","volume":"2","author":"N Takahashi","year":"2022","unstructured":"Takahashi, N. et al. Replication stress defines distinct molecular subtypes across cancers. Cancer Res. Commun. 2, 503\u2013517 (2022).","journal-title":"Cancer Res. Commun."},{"key":"74588_CR3","doi-asserted-by":"publisher","first-page":"T23","DOI":"10.1530\/ERC-17-0187","volume":"24","author":"SE McClelland","year":"2017","unstructured":"McClelland, S. E. Role of chromosomal instability in cancer progression. Endocr. Relat. Cancer 24, T23\u2013T31 (2017).","journal-title":"Endocr. Relat. Cancer"},{"key":"74588_CR4","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/genes11060642","volume":"11","author":"T Wilhelm","year":"2020","unstructured":"Wilhelm, T., Said, M. & Naim, V. DNA replication stress and chromosomal instability: dangerous liaisons. Genes 11, 642 (2020).","journal-title":"Genes"},{"key":"74588_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-024-01767-7","volume":"9","author":"R Hosea","year":"2024","unstructured":"Hosea, R., Hillary, S., Naqvi, S., Wu, S. & Kasim, V. The two sides of chromosomal instability: drivers and brakes in cancer. Signal Transduct. Target. Ther. 9, 75 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"74588_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/ijms25021263","volume":"25","author":"AI Khamidullina","year":"2024","unstructured":"Khamidullina, A. I., Abramenko, Y. E., Bruter, A. V. & Tatarskiy, V. V. Key proteins of replication stress response and cell cycle control as cancer therapy targets. Int. J. Mol. Sci. 25, 1263 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"74588_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41568-022-00518-6","volume":"23","author":"E Cybulla","year":"2023","unstructured":"Cybulla, E. & Vindigni, A. Leveraging the replication stress response to optimize cancer therapy. Nat. Rev. Cancer 23, 6\u201324 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"74588_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrm.2017.67","volume":"18","author":"JC Saldivar","year":"2017","unstructured":"Saldivar, J. C., Cortez, D. & Cimprich, K. A. The essential kinase ATR: ensuring faithful duplication of a challenging genome. Nat. Rev. Mol. Cell Biol. 18, 622\u2013636 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"74588_CR9","doi-asserted-by":"publisher","first-page":"13374","DOI":"10.1073\/pnas.1903418116","volume":"116","author":"TN Moiseeva","year":"2019","unstructured":"Moiseeva, T. N. et al. An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication. Proc. Natl. Acad. Sci. USA 116, 13374\u201313383 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74588_CR10","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","volume":"82","author":"S Saxena","year":"2022","unstructured":"Saxena, S. & Zou, L. Hallmarks of DNA replication stress. Mol. Cell 82, 2298\u20132314 (2022).","journal-title":"Mol. Cell"},{"key":"74588_CR11","doi-asserted-by":"publisher","first-page":"111836","DOI":"10.1016\/j.celrep.2022.111836","volume":"41","author":"N B\u00f6hly","year":"2022","unstructured":"B\u00f6hly, N. et al. Increased replication origin firing links replication stress to whole chromosomal instability in human cancer. Cell Rep. 41, 111836 (2022).","journal-title":"Cell Rep."},{"key":"74588_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/ijms25052767","volume":"25","author":"D Mavroeidi","year":"2024","unstructured":"Mavroeidi, D., Georganta, A., Panagiotou, E., Syrigos, K. & Souliotis, V. L. Targeting ATR pathway in solid tumors: evidence of improving therapeutic outcomes. Int. J. Mol. Sci. 25, 5 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"74588_CR13","doi-asserted-by":"publisher","first-page":"100017","DOI":"10.1016\/j.crphar.2021.100017","volume":"2","author":"FM Barnieh","year":"2021","unstructured":"Barnieh, F. M., Loadman, P. M. & Falconer, R. A. Progress towards a clinically-successful ATR inhibitor for cancer therapy. Curr. Res. Pharmacol. Drug Discov. 2, 100017 (2021).","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"74588_CR14","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1158\/1078-0432.CCR-22-2444","volume":"29","author":"SL Wethington","year":"2023","unstructured":"Wethington, S. L. et al. Combination ATR (ceralasertib) and PARP (olaparib) inhibitor (CAPRI) trial in acquired PARP inhibitor\u2013resistant homologous recombination\u2013deficient ovarian cancer. Clin. Cancer Res. 29, 2800\u20132807 (2023).","journal-title":"Clin. Cancer Res."},{"key":"74588_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41591-024-02808-y","volume":"30","author":"B Besse","year":"2024","unstructured":"Besse, B. et al. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial. Nat. Med. 30, 716\u2013729 (2024).","journal-title":"Nat. Med."},{"key":"74588_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41571-024-00863-5","volume":"21","author":"NYL Ngoi","year":"2024","unstructured":"Ngoi, N. Y. L. et al. Targeting ATR in patients with cancer. Nat. Rev. Clin. Oncol. 21, 278\u2013293 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"74588_CR17","doi-asserted-by":"publisher","first-page":"e80314","DOI":"10.1371\/journal.pone.0080314","volume":"8","author":"MA Merritt","year":"2013","unstructured":"Merritt, M. A. et al. Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes. PLoS ONE 8, e80314 (2013).","journal-title":"PLoS ONE"},{"key":"74588_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02781-0","volume":"23","author":"N Shaikh","year":"2022","unstructured":"Shaikh, N. et al. Replication stress generates distinctive landscapes of DNA copy number alterations and chromosome scale losses. Genome Biol. 23, 223 (2022).","journal-title":"Genome Biol."},{"key":"74588_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature25507","volume":"555","author":"M Macheret","year":"2018","unstructured":"Macheret, M. & Halazonetis, T. D. Intragenic origins due to short G1 phases underlie oncogene-induced DNA replication stress. Nature 555, 112\u2013116 (2018).","journal-title":"Nature"},{"key":"74588_CR20","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1038\/onc.2012.387","volume":"32","author":"RM Jones","year":"2013","unstructured":"Jones, R. M. et al. Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress. Oncogene 32, 3744\u20133753 (2013).","journal-title":"Oncogene"},{"key":"74588_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-00270-2","volume":"9","author":"YP Kok","year":"2020","unstructured":"Kok, Y. P. et al. Overexpression of Cyclin E1 or Cdc25A leads to replication stress, mitotic aberrancies, and increased sensitivity to replication checkpoint inhibitors. Oncogenesis 9, 88 (2020).","journal-title":"Oncogenesis"},{"key":"74588_CR22","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1158\/1538-7445.AM2018-5107","volume":"78","author":"B Kumar","year":"2018","unstructured":"Kumar, B. et al. Normal breast-derived epithelial cells with luminal and intrinsic subtype-enriched gene expression document interindividual differences in their differentiation cascade. Cancer Res. 78, 5107\u20135123 (2018).","journal-title":"Cancer Res."},{"key":"74588_CR23","doi-asserted-by":"publisher","first-page":"100394","DOI":"10.1016\/j.xcrm.2021.100394","volume":"2","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models. Cell Rep. Med. 2, 100394 (2021).","journal-title":"Cell Rep. Med."},{"key":"74588_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature11935","volume":"494","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A. et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 494, 492\u2013496 (2013).","journal-title":"Nature"},{"key":"74588_CR25","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1158\/0008-5472.CAN-19-0852","volume":"80","author":"N Tamura","year":"2020","unstructured":"Tamura, N. et al. Specific mechanisms of chromosomal instability indicate therapeutic sensitivities in high-grade serous ovarian carcinoma. Cancer Res. 80, 4946\u20134959 (2020).","journal-title":"Cancer Res."},{"key":"74588_CR26","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1158\/0008-5472.CAN-18-2480","volume":"79","author":"LA Young","year":"2019","unstructured":"Young, L. A. et al. Differential activity of ATR and WEE1 inhibitors in a highly sensitive subpopulation of DLBCL linked to replication stress. Cancer Res. 79, 3762\u20133775 (2019).","journal-title":"Cancer Res."},{"key":"74588_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63168-w","volume":"16","author":"MJK Jones","year":"2025","unstructured":"Jones, M. J. K. et al. A high-resolution, nanopore-based artificial intelligence assay for DNA replication stress in human cancer cells. Nat. Commun. 16, 7732 (2025).","journal-title":"Nat. Commun."},{"key":"74588_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.cell.2011.03.044","volume":"145","author":"AC Bester","year":"2011","unstructured":"Bester, A. C. et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145, 435\u2013446 (2011).","journal-title":"Cell"},{"key":"74588_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.dnarep.2018.09.003","volume":"72","author":"TN Moiseeva","year":"2018","unstructured":"Moiseeva, T. N. & Bakkenist, C. J. Regulation of the initiation of DNA replication in human cells. DNA Repair 72, 99\u2013106 (2018).","journal-title":"DNA Repair"},{"key":"74588_CR30","doi-asserted-by":"publisher","first-page":"113797","DOI":"10.1016\/j.biopha.2022.113797","volume":"155","author":"S Ahmed","year":"2022","unstructured":"Ahmed, S. et al. Natural products targeting the ATR-CHK1 signaling pathway in cancer therapy. Biomed. Pharmacother. 155, 113797 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"74588_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-0716-1936-0_8","volume":"2420","author":"P Casado","year":"2022","unstructured":"Casado, P., Hijazi, M., Gerdes, H. & Cutillas, P. R. Implementation of clinical phosphoproteomics and proteomics for personalized medicine. Methods Mol. Biol. 2420, 87\u2013106 (2022).","journal-title":"Methods Mol. Biol."},{"key":"74588_CR32","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1140321","volume":"316","author":"S Matsuoka","year":"2007","unstructured":"Matsuoka, S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160\u20131166 (2007).","journal-title":"Science"},{"key":"74588_CR33","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.cell.2013.10.043","volume":"155","author":"LI Toledo","year":"2013","unstructured":"Toledo, L. I. et al. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell 155, 1088\u20131103 (2013).","journal-title":"Cell"},{"key":"74588_CR34","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.molcel.2017.05.001","volume":"66","author":"L Toledo","year":"2017","unstructured":"Toledo, L., Neelsen, K. J. & Lukas, J. Replication catastrophe: when a checkpoint fails because of exhaustion. Mol. Cell 66, 735\u2013749 (2017).","journal-title":"Mol. Cell"},{"key":"74588_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/cancers11030355","volume":"11","author":"E Moeglin","year":"2019","unstructured":"Moeglin, E. et al. Uniform widespread nuclear phosphorylation of histone H2AX is an indicator of lethal DNA replication stress. Cancers 11, 3 (2019).","journal-title":"Cancers"},{"key":"74588_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201208060","volume":"201","author":"Y Zhong","year":"2013","unstructured":"Zhong, Y. et al. The level of origin firing inversely affects the rate of replication fork progression. J. Cell Biol. 201, 373\u2013383 (2013).","journal-title":"J. Cell Biol."},{"key":"74588_CR37","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1073\/pnas.1005031107","volume":"107","author":"E Petermann","year":"2010","unstructured":"Petermann, E., Woodcock, M. & Helleday, T. Chk1 promotes replication fork progression by controlling replication initiation. Proc. Natl. Acad. Sci. USA 107, 16090\u201316095 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74588_CR38","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1083\/jcb.201007074","volume":"191","author":"XQ Ge","year":"2010","unstructured":"Ge, X. Q. & Blow, J. J. Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories. J. Cell Biol. 191, 1285\u20131297 (2010).","journal-title":"J. Cell Biol."},{"key":"74588_CR39","doi-asserted-by":"publisher","first-page":"e101284","DOI":"10.15252\/embj.2018101284","volume":"38","author":"MA Gonz\u00e1lez Besteiro","year":"2019","unstructured":"Gonz\u00e1lez Besteiro, M. A. et al. Chk1 loss creates replication barriers that compromise cell survival independently of excess origin firing. EMBO J. 38, e101284 (2019).","journal-title":"EMBO J."},{"key":"74588_CR40","doi-asserted-by":"publisher","first-page":"18164","DOI":"10.1021\/acs.jmedchem.5c01478","volume":"68","author":"A Ghosh","year":"2025","unstructured":"Ghosh, A. et al. Discovery of AZD8421: a potent CDK2 inhibitor with selectivity against other CDK family members and the human kinome. J. Med. Chem. 68, 18164\u201318177 (2025).","journal-title":"J. Med. Chem."},{"key":"74588_CR41","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio, F. et al. A landscape of pharmacogenomic interactions in cancer. Cell 166, 740\u2013754 (2016).","journal-title":"Cell"},{"key":"74588_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","volume":"23","author":"\u015eK \u00c7orbac\u0131o\u011flu","year":"2023","unstructured":"\u00c7orbac\u0131o\u011flu, \u015eK. & Aksel, G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: a guide to interpreting the area under the curve value. Turk. J. Emerg. Med. 23, 195\u2013198 (2023).","journal-title":"Turk. J. Emerg. Med."},{"key":"74588_CR43","doi-asserted-by":"publisher","first-page":"362.e13","DOI":"10.1053\/j.gastro.2020.09.043","volume":"160","author":"SB Dreyer","year":"2021","unstructured":"Dreyer, S. B. et al. Targeting DNA damage response and replication stress in pancreatic cancer. Gastroenterology 160, 362.e13\u2013377.e13 (2021).","journal-title":"Gastroenterology"},{"key":"74588_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13578-018-0242-2","volume":"8","author":"L Fei","year":"2018","unstructured":"Fei, L. & Xu, H. Role of MCM2\u20137 protein phosphorylation in human cancer cells. Cell Biosci. 8, 43 (2018).","journal-title":"Cell Biosci."},{"key":"74588_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/cjp2.269","volume":"8","author":"D Aziz","year":"2022","unstructured":"Aziz, D. et al. High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer. J. Pathol. Clin. Res. 8, 355\u2013370 (2022).","journal-title":"J. Pathol. Clin. Res."},{"key":"74588_CR46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1097-2765(02)00799-2","volume":"11","author":"V Costanzo","year":"2003","unstructured":"Costanzo, V. et al. An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol. Cell 11, 203\u2013213 (2003).","journal-title":"Mol. Cell"},{"key":"74588_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01401-x","volume":"8","author":"T Moiseeva","year":"2017","unstructured":"Moiseeva, T. et al. ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1. Nat. Commun. 8, 1392 (2017).","journal-title":"Nat. Commun."},{"key":"74588_CR48","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.4161\/cc.3.12.1272","volume":"3","author":"S Squires","year":"2004","unstructured":"Squires, S. et al. p53 prevents the accumulation of double-strand DNA breaks at stalled-replication forks induced by UV in human cells. Cell Cycle 3, 1543\u20131557 (2004).","journal-title":"Cell Cycle"},{"key":"74588_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00981-0","volume":"13","author":"Y Guo","year":"2021","unstructured":"Guo, Y. et al. Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer. Genome Med. 13, 166 (2021).","journal-title":"Genome Med."},{"key":"74588_CR50","doi-asserted-by":"publisher","first-page":"106951","DOI":"10.1016\/j.isci.2023.106951","volume":"26","author":"A G\u00f6der","year":"2023","unstructured":"G\u00f6der, A. et al. PTBP1 enforces ATR-CHK1 signaling determining the potency of CDC7 inhibitors. iScience 26, 106951 (2023).","journal-title":"iScience"},{"key":"74588_CR51","doi-asserted-by":"publisher","first-page":"108096","DOI":"10.1016\/j.celrep.2020.108096","volume":"32","author":"MD Rainey","year":"2020","unstructured":"Rainey, M. D. et al. ATR restrains DNA synthesis and mitotic catastrophe in response to CDC7 inhibition. Cell Rep. 32, 108096 (2020).","journal-title":"Cell Rep."},{"key":"74588_CR52","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1080\/15384101.2016.1152424","volume":"15","author":"C K\u00f6hler","year":"2016","unstructured":"K\u00f6hler, C. et al. Cdc45 is limiting for replication initiation in humans. Cell Cycle 15, 974\u2013985 (2016).","journal-title":"Cell Cycle"},{"key":"74588_CR53","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1021\/pr400032m","volume":"12","author":"GS McDowell","year":"2013","unstructured":"McDowell, G. S., Gaun, A. & Steen, H. iFASP: Combining isobaric mass tagging with filter-aided sample preparation. J. Proteome Res. 12, 3809\u20133812 (2013).","journal-title":"J. Proteome Res."},{"key":"74588_CR54","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301\u20132319 (2016).","journal-title":"Nat. Protoc."},{"key":"74588_CR55","doi-asserted-by":"publisher","first-page":"rs6","DOI":"10.1126\/scisignal.2003573","volume":"6","author":"P Casado","year":"2013","unstructured":"Casado, P. et al. Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci. Signal. 6, rs6 (2013).","journal-title":"Sci. Signal."},{"key":"74588_CR56","doi-asserted-by":"publisher","first-page":"D433","DOI":"10.1093\/nar\/gky1159","volume":"47","author":"PV Hornbeck","year":"2019","unstructured":"Hornbeck, P. V. et al. 15 years of PhosphoSitePlus\u00ae: integrating post-translationally modified sites, disease variants and isoforms. Nucleic Acids Res. 47, D433\u2013D441 (2019).","journal-title":"Nucleic Acids Res."},{"key":"74588_CR57","doi-asserted-by":"publisher","first-page":"D631","DOI":"10.1093\/nar\/gkac883","volume":"51","author":"P Lo Surdo","year":"2023","unstructured":"Lo Surdo, P. et al. SIGNOR 3.0, the SIGnaling network open resource 3.0: 2022 update. Nucleic Acids Res. 51, D631\u2013D637 (2023).","journal-title":"Nucleic Acids Res."},{"key":"74588_CR58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-1-4939-7493-1_6","volume":"1711","author":"J Wirbel","year":"2017","unstructured":"Wirbel, J., Cutillas, P. & Saez-Rodriguez, J. Phosphoproteomics-based profiling of kinase activities in cancer cells. Methods Mol. Biol. 1711, 103\u2013132 (2017).","journal-title":"Methods Mol. Biol."},{"key":"74588_CR59","first-page":"1","volume":"8","author":"P Casado","year":"2023","unstructured":"Casado, P. et al. Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. Signal Transduct. Target. Ther. 8, 1 (2023).","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74588-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74588-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74588-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:02:09Z","timestamp":1785844929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74588-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74588"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74588-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.V.F. is a full-time employee and holds shares at AstraZeneca. M.A.B. is a project co-lead on a BBSRC Industrial Partnership Award (UKRI1912) where Oxford Nanopore Technologies is a project partner. P.L.P. received funding from Oxford Nanopore Technologies to present parts of this work at the EMBO EMBL Symposium AI and Biology. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7761"}}